Key points
PMF patients with a JAK2 mutation have a higher PD-L1 expression than
patients with JAK2-unmutated PMF or control groups.
A lower PD-L1 expression in PMF resulted in longer overall survival
compared to patients with a higher PD-L1 expression score.